Filing Details

Accession Number:
0000899866-14-000273
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-19 16:49:22
Reporting Period:
2014-12-18
Filing Date:
2014-12-19
Accepted Time:
2014-12-19 16:49:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457477 David Hallal C/O Alexion Pharmaceuticals, Inc
352 Knotter Drive
Cheshire CT 06410
Chief Operating Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Disposition 2014-12-18 5,494 $182.03 113,122 No 4 S Indirect Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Family Trust
Footnotes
  1. The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
  2. This sale consists of Alexion common stock contributed by the reporting person to an exchange fund in exchange for shares of the exchange fund. The Alexion shares were valued at $182.03 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.